Integrated Research Limited (IRI.AX)
North Sydney, NSW, AU
Integrated Research Limited (IRI.AX), an Australian company founded in North Sydney in 1988, specializes in developing, deploying, and selling computer software for managing critical IT systems. Their solutions address business-critical computing, unified communication, and payment networks. The company's flagship product, Prognosis, is a comprehensive software suite engineered to provide management and technical teams with detailed operational insight into platforms such as HP NonStop, distributed system servers, unified communications environments, payment infrastructures, and core business applications. Beyond software, they also deliver testing, maintenance, and professional services, including a Software-as-a-Service (SaaS) option. Integrated Research operates globally, reaching clients in approximately 60 countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, complemented by a broad international channel-driven distribution network. Their diverse customer base includes financial institutions like stock exchanges, banks, and credit card companies, alongside telecommunications carriers, service providers, and manufacturers.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +1.69% | +1.69% | +1.69% | -1.64% | -14.29% | -31.82% | -11.76% | -87.01% | -85.15% | -84.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Software - Application: +13.0%-18.1% Q4'25: -30.6% (vs Q4'23)
-
EPS growth Software - Application: +28.6%-50.5% Q4'25: -113.3% (vs Q4'23)
-
FCF margin FCF growth · Software - Application: +45.3%+7.1% Q4'25: +25.5% (vs Q4'23)
-
EBIT margin Software - Application: +9.4%+19.6% ★ Q4'25: -11.9% (vs Q4'23)
-
ROIC Software - Application: +7.5%+15.7% ★ Q4'25: -23.7% (vs Q4'23)
-
Share dilution Software - Application: +0.0%+0.6% Q4'25: +2.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Software - Application: -1.16×0.14× ★ Q4'25: -0.18× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2001 actual |
Jun 2002 actual |
Jun 2003 actual |
Jun 2006 actual |
Jun 2007 actual |
Jun 2008 actual |
Jun 2009 actual |
Jun 2010 actual |
Jun 2011 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
28.10M
est: 29.55M (-4.9%)
|
32.31M
est: 33.72M (-4.2%)
|
27.51M
est: 27.48M (+0.1%)
|
—
est: 36.82M (-100.0%)
|
36.38M
est: 36.98M (-1.6%)
|
37.38M
est: 44.51M (-16.0%)
|
42.68M
est: 37.19M (+14.8%)
|
37.30M
est: 39.11M (-4.6%)
|
44.59M
est: 44.56M (+0.1%)
|
48.86M
est: 53.54M (-8.7%)
|
53.24M
est: 54.87M (-3.0%)
|
70.28M
est: 65.80M (+6.8%)
|
84.53M
est: 83.90M (+0.8%)
|
91.17M
est: 91.70M (-0.6%)
|
91.18M
est: 94.15M (-3.2%)
|
100.82M
est: 103.15M (-2.3%)
|
110.91M
est: 110.00M (+0.8%)
|
78.49M
est: 78.40M (+0.1%)
|
62.87M
est: 63.40M (-0.8%)
|
69.83M
est: 69.80M (+0.0%)
|
83.29M
est: 82.40M (+1.1%)
|
68.26M
est: 68.00M (+0.4%)
|
60.00M
60.00M – 60.00M
-11.8% YoY
|
71.00M
71.00M – 71.00M
+18.3% YoY
|
77.50M
77.50M – 77.50M
+9.2% YoY
|
| EBITDA |
6.41M
est: 5.61M (+14.3%)
|
11.01M
est: 8.10M (+35.8%)
|
5.27M
est: 6.76M (-22.1%)
|
-26.92M
est: 6.85M (-493.1%)
|
6.98M
est: 8.44M (-17.3%)
|
7.21M
est: 9.51M (-24.2%)
|
9.37M
est: 6.85M (+36.7%)
|
5.71M
est: 10.94M (-47.8%)
|
10.48M
est: 8.29M (+26.5%)
|
10.52M
est: 8.63M (+22.0%)
|
10.63M
est: 12.40M (-14.2%)
|
17.47M
est: 13.35M (+30.9%)
|
32.06M
est: 25.25M (+27.0%)
|
26.62M
est: 23.88M (+11.5%)
|
36.95M
est: 26.27M (+40.7%)
|
41.03M
est: 28.72M (+42.9%)
|
43.92M
est: 20.87M (+110.4%)
|
23.34M
est: 14.88M (+56.9%)
|
10.40M
est: 12.03M (-13.6%)
|
-1.07M
est: 42.11M (-102.5%)
|
25.35M
est: 46.13M (-45.1%)
|
13.45M
est: 12.90M (+4.3%)
|
11.39M
11.39M – 11.39M
-11.8% YoY
|
13.47M
13.47M – 13.47M
+18.3% YoY
|
14.71M
14.71M – 14.71M
+9.2% YoY
|
| EBIT |
4.47M
est: 2.38M (+87.7%)
|
8.51M
est: 8.10M (+5.0%)
|
1.60M
est: 6.76M (-76.4%)
|
—
est: 2.91M (-100.0%)
|
6.98M
est: 7.63M (-8.5%)
|
534.0K
est: 8.43M (-93.7%)
|
3.68M
est: 2.94M (+25.4%)
|
-1.07M
est: 3.09M (-134.5%)
|
3.92M
est: 3.52M (+11.4%)
|
11.57M
est: 7.80M (+48.3%)
|
3.08M
est: 11.37M (-72.9%)
|
8.35M
est: 12.38M (-32.6%)
|
21.51M
est: 24.49M (-12.2%)
|
26.62M
est: 23.71M (+12.2%)
|
26.37M
est: 25.92M (+1.7%)
|
29.70M
est: 27.81M (+6.8%)
|
31.86M
est: 8.86M (+259.4%)
|
9.91M
est: 6.32M (+56.8%)
|
-2.39M
est: 5.11M (-146.8%)
|
-12.86M
est: 40.52M (-131.7%)
|
25.23M
est: 44.39M (-43.2%)
|
13.37M
est: 48.71M (-72.6%)
|
4.83M
4.83M – 4.83M
-90.1% YoY
|
5.72M
5.72M – 5.72M
+18.3% YoY
|
6.25M
6.25M – 6.25M
+9.2% YoY
|
| Net Income |
5.02M
est: 6.18M (-18.7%)
|
6.52M
est: 5.71M (+14.3%)
|
1.07M
est: 5.30M (-79.8%)
|
7.00M
est: 7.85M (-10.8%)
|
5.43M
est: 7.03M (-22.7%)
|
5.78M
est: 6.50M (-11.1%)
|
7.86M
est: 5.48M (+43.6%)
|
5.40M
est: 6.02M (-10.3%)
|
7.47M
est: 7.67M (-2.6%)
|
9.08M
est: 7.39M (+22.8%)
|
8.49M
est: 9.33M (-9.0%)
|
14.25M
est: 10.22M (+39.4%)
|
16.03M
est: 18.40M (-12.9%)
|
18.52M
est: 17.80M (+4.0%)
|
19.18M
est: 18.67M (+2.7%)
|
21.85M
est: 20.63M (+5.9%)
|
24.05M
est: 25.00M (-3.8%)
|
7.94M
est: 7.55M (+5.1%)
|
1.55M
est: 899.2K (+71.8%)
|
-29.23M
est: 2.52M (-1,260.9%)
|
27.13M
est: 27.13M (+0.0%)
|
13.36M
est: 14.39M (-7.1%)
|
-1.26M
-1.26M – -1.26M
-108.7% YoY
|
3.78M
3.78M – 3.78M
+400.0% YoY
|
6.29M
6.29M – 6.29M
+66.7% YoY
|
| SGA |
17.68M
est: 18.97M (-6.8%)
|
18.92M
est: 20.20M (-6.3%)
|
20.34M
est: 16.13M (+26.1%)
|
20.23M
est: 23.17M (-12.7%)
|
23.03M
est: 20.29M (+13.5%)
|
14.79M
est: 27.68M (-46.6%)
|
25.07M
est: 23.40M (+7.1%)
|
23.25M
est: 26.40M (-11.9%)
|
25.16M
est: 28.05M (-10.3%)
|
27.56M
est: 31.90M (-13.6%)
|
31.54M
est: 28.28M (+11.5%)
|
40.38M
est: 37.88M (+6.6%)
|
50.95M
est: 52.13M (-2.3%)
|
49.69M
est: 56.58M (-12.2%)
|
51.55M
est: 50.10M (+2.9%)
|
55.34M
est: 55.46M (-0.2%)
|
60.79M
est: 70.62M (-13.9%)
|
49.61M
est: 50.34M (-1.4%)
|
47.38M
est: 40.70M (+16.4%)
|
47.20M
est: 44.81M (+5.3%)
|
45.17M
est: 52.90M (-14.6%)
|
41.37M
est: 43.66M (-5.2%)
|
38.52M
38.52M – 38.52M
-11.8% YoY
|
45.58M
45.58M – 45.58M
+18.3% YoY
|
49.76M
49.76M – 49.76M
+9.2% YoY
|
| EPS |
0.03
est: 0.03 (-10.6%)
|
0.04
est: 0.04 (+2.9%)
|
0.01
est: 0.00 (+60.9%)
|
0.04
est: 0.04 (-2.8%)
|
0.03
est: 0.03 (-3.4%)
|
0.03
est: 0.05 (-28.4%)
|
0.05
est: 0.03 (+55.8%)
|
0.03
est: 0.03 (-2.8%)
|
0.04
est: 0.04 (+5.4%)
|
0.05
est: 0.06 (-7.0%)
|
0.05
est: 0.07 (-27.8%)
|
0.08
est: 0.08 (+2.6%)
|
0.09
est: 0.09 (+2.4%)
|
0.11
est: 0.11 (+2.8%)
|
0.11
est: 0.11 (-0.5%)
|
0.13
est: 0.13 (+2.8%)
|
0.14
est: 0.14 (+0.7%)
|
0.05
est: 0.04 (+9.8%)
|
0.01
est: 0.01 (+80.0%)
|
-0.17
est: 0.01 (-1,314.3%)
|
0.16
est: 0.12 (+29.0%)
|
0.08
est: 0.08 (-5.5%)
|
-0.01
-0.01 – -0.01
-108.8% YoY
|
0.02
0.02 – 0.02
+400.0% YoY
|
0.04
0.04 – 0.04
+66.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-28 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-27 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-26 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-25 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-22 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-21 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-20 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-19 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-18 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 4/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-08 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-07 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-06 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-05 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-04 | A+ | 5/5 | 5/5 | 3/5 | 4/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-01 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-29 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-28 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-27 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-24 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-23 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-22 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-21 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-20 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-17 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-16 | A+ | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ian Lowe ASCM | Chief Executive Officer, MD & Director | 622.1K | male |
| Christian Shaw | Chief Financial Officer | 440.2K | male |
| Stephen John Killelea | Advisor | 64.1K | male |
| Geoff Sieron | Senior Vice President of IR Labs | — | male |
| Elie Shuggi | Chief Product Officer | — | male |
| Gemma Garkut | Head of Communications & IR | — | female |
| Marco Cantamessi | Senior Vice President of Global Sales | — | male |
| Michael Tomkins | Chief Technology Officer | — | male |
| Leanne Ralph | Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for IRI.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
